Evidence map›Paper›PMID 23686486›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology.

Amol Suryawanshi, Zhiyi Cao, Thananya Thitiprasert, Tanveer S Zaidi, Noorjahan Panjwani

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. The Role ofPharmaceutics · 2024
    Review
  4. Review
  5. IL-36α Enhances Host Defense againstJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  6. Review
  7. Galectins as Regulators of Corneal Inflammation.Current opinion in physiology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. MicroRNAs in Ocular Infection.Microorganisms · 2019
    Review
  12. Review
  13. Glycosylation-dependent galectin-receptor interactions promoteProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Review
  15. Article
  16. Challenges of corneal infections.Expert review of ophthalmology · 2016
    Article
  17. Article
  18. IL-17A-mediated protection against Acanthamoeba keratitis.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amol SuryawanshiNew England Eye Center, Tufts University School of Medicine, Boston, MA 02111, USA.
Zhiyi Cao
Thananya Thitiprasert
Tanveer S Zaidi
Noorjahan Panjwani
Tufts University · USBrigham and Women's Hospital · US

Funding

The Role of Galectins in Corneal Hem- and LymphangiogenesisR01EY007088 · NEI · TUFTS UNIVERSITY BOSTON · PI PANJWANI, NOORJAHAN · 1987 to 2015
$3.6M
PATHOGENESIS OF ACANTHAMOEBA KERATITISR01EY009349 · NEI · TUFTS UNIVERSITY BOSTON · PI PANJWANI, NOORJAHAN · 1993 to 2013
$3.4M
SHORT TERM TRAINING--STUDENTS IN HEALTH PROFESSIONST35EY007088 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FRISHMAN, LAURA J. · 1985 to 2025
$2.3M
The Role of Selectin-Mediated Recognition in GlaucomaR03EY015168 · NEI · TUFTS UNIVERSITY BOSTON · PI PANJWANI, NOORJAHAN · 2004 to 2006
$487k
FMRI STUDIES;VISUAL EXPERIENCE AND NEURONAL CHANGESF32EY007088 · NEI · MAX PLANCK INST/BIOLOGICAL CYBERNETICS · PI TOLIAS, ANDREAS SAVAS · 2000 to 2003
$116k
NEI NIH HHS EY007088NEI NIH HHS EY009349NEI NIH HHS F32 EY007088NEI NIH HHS R01 EY007088NEI NIH HHS R01 EY009349NEI NIH HHS R03 EY015168NEI NIH HHS T35 EY007088
6 · The paper itself

Abstract

Corneal infection with Pseudomonas aeruginosa leads to a severe immunoinflammatory lesion, often causing vision impairment and blindness. Although past studies have indicated a critical role for CD4(+) T cells, particularly Th1 cells, in corneal immunopathology, the relative contribution of recently discovered Th17 and regulatory T cells is undefined. In this study, we demonstrate that after corneal P. aeruginosa infection, both Th1 and Th17 cells infiltrate the cornea with increased representation of Th17 cells. In addition to Th1 and Th17 cells, regulatory T cells also migrate into the cornea during early as well as late stages of corneal pathology. Moreover, using galectin-1 (Gal-1), an immunomodulatory carbohydrate-binding molecule, we investigated whether shifting the balance among various CD4(+) T cell subsets can modulate P. aeruginosa-induced corneal immunopathology. We demonstrate in this study that local recombinant Gal-1 (rGal-1) treatment by subconjunctival injections significantly diminishes P. aeruginosa-mediated corneal inflammation through multiple mechanisms. Specifically, in our study, rGal-1 treatment significantly diminished corneal infiltration of total CD45(+) T cells, neutrophils, and CD4(+) T cells. Furthermore, rGal-1 treatment significantly reduced proinflammatory Th17 cell response in the cornea as well as local draining lymph nodes. Also, rGal-1 therapy promoted anti-inflammatory Th2 and IL-10 response in secondary lymphoid organs. Collectively, our results indicate that corneal P. aeruginosa infection induces a strong Th17-mediated corneal pathology, and treatment with endogenously derived protein such as Gal-1 may be of therapeutic value for the management of bacterial keratitis, a prevalent cause of vision loss and blindness in humans worldwide.

Indexed as

AnimalsCorneaEnzyme-Linked Immunosorbent AssayEye Infections, BacterialFlow CytometryGalectin 1KeratitisMiceMice, Inbred C57BLPseudomonas aeruginosaPseudomonas InfectionsTh17 CellsTh1 CellsT-Lymphocytes, RegulatoryGalectin 1

Identifiers

PMID23686486
PMCPMC3689592
OpenAlexW1805095798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.